Pivampicillin
From Wikipedia, the free encyclopedia
 |
|
|
Pivampicillin
|
|
| Systematic (IUPAC) name | |
| 2,2-dimethylpropanoyloxymethyl (2S,5R,6R)- 6-{[(2R)-2-amino-2-phenyl-acetyl]amino}-3,3- dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0] heptane-2-carboxylate |
|
| Identifiers | |
| CAS number | 33817-20-8 |
| ATC code | J01CA02 |
| PubChem | 33478 |
| Chemical data | |
| Formula | C22H29N3O6S |
| Mol. weight | 463.548 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | Renal (76%) |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
Pivampicillin is a pivaloyloxymethylester of ampicillin. It is a prodrug, which is thought to enhance the oral bioavailability of ampicillin because of its greater lipophilicity compared to that of ampicillin.
| Penicillins (J01C) edit | ||
|---|---|---|
|
Amoxicillin, Ampicillin, Azlocillin, Carbenicillin, Cloxacillin, Dicloxacillin, Flucloxacillin, Mezlocillin, Nafcillin, Piperacillin, Pivampicillin, Ticarcillin |
||
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
